Evidence map›Paper›PMID 38957387›Full record

ArticleFrontiers in pharmacology2024

Antimalarial and antioxidant activities of novel artesunate-ellagic acid hybrid compound

Ahmed A Ishola, Joseph O Adebayo, Isabela P Ceravolo, Habibu Tijjani, Edson S Bento, Henrique F Goulart, Alessandre C Crispim, Elizabeth A Balogun, Antonio E G Santana, Antoniana U Krettli

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pharmacology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Ellagic Acid fromMolecules (Basel, Switzerland) · 2025
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ahmed A IsholaDepartment of Biochemistry, University of Ilorin, Ilorin, Nigeria.
Joseph O AdebayoDepartment of Biochemistry, University of Ilorin, Ilorin, Nigeria.
Isabela P CeravoloMalária Experimentale Humana, Instituto René Rachou, Fundacao Oswaldo Cruz, Belo Horizonte, Mato Grosso, Brazil.
Habibu TijjaniDepartment of Biochemistry, Bauchi State University, Gadau, Nigeria.
Edson S BentoInstituto de Quimica e Biotecnologia, Universidade Federal de Alagoas (UFAL), Maceio, Alagoas, Brazil.
Henrique F GoulartLaboratório de Pesquisa Em Recursos Naturais (LPqRN), Campus de Engenharias Ciencias Agrárias, Rio Largo, Brazil.
Alessandre C CrispimInstituto de Quimica e Biotecnologia, Universidade Federal de Alagoas (UFAL), Maceio, Alagoas, Brazil.
Elizabeth A BalogunDepartment of Biochemistry, University of Ilorin, Ilorin, Nigeria.
Antonio E G SantanaLaboratório de Pesquisa Em Recursos Naturais (LPqRN), Campus de Engenharias Ciencias Agrárias, Rio Largo, Brazil.
Antoniana U KrettliMalária Experimentale Humana, Instituto René Rachou, Fundacao Oswaldo Cruz, Belo Horizonte, Mato Grosso, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

antimalarialantioxidantartesunateellagic acidhybrid compound

Identifiers

PMID38957387
PMCPMC11217523

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.